Figure 2.

Community prevalence estimates for celiac disease (CD). Estimated prevalence of CD with 95% confidence intervals per 1,000 adult females (F) or male (M) subjects, based upon enrichment of human leukocyte antigen (HLA)-DQ2.5, DQ8, and DQ2.2 in subjects who were seropositive for transglutaminase (TG)2 IgA (TG2+), TG2 IgA+ and then endomysial antibody (EMA)+, composite TG2/DGP IgA/IgG (Comp+), Comp.+ and then TG2 IgA+, deamidated gliadin-derived peptide (DGP)-G+ or DGP-A+ (Comp + One+), and for Comp+ and then TG2 IgA+, DGP-G+ and DGP-A+ (Comp + All+).